Amlexanox
From Wikipedia, the free encyclopedia
 |
|
|
Amlexanox
|
|
| Systematic (IUPAC) name | |
| 2-amino-7-(1-methylethyl)-5-oxo-5H-chromeno[2,3-b] pyridine-3-carboxylic acid |
|
| Identifiers | |
| CAS number | |
| ATC code | A01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C16H14N2O4 |
| Mol. mass | 298.293 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 3.5 hours |
| Excretion | Renal (17%) |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Topical |
Amlexanox is a medication with antiallergic and anti-inflammatory effects used in the treatment of aphthous ulcers (canker sores).
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||
